Literature DB >> 1321219

Identification of the glycoprotein H gene of murine cytomegalovirus.

J Xu1, P B Dallas, P A Lyons, G R Shellam, A A Scalzo.   

Abstract

Partial sequencing of the HindIII C fragment of murine cytomegalovirus (MCMV) revealed an open reading frame of 2172 nucleotides in length encoding a 724 amino acid protein with a predicted Mr of 80.4K. Analysis of the predicted amino acid sequence revealed homology with glycoprotein H (gH) from a number of other herpesviruses. MCMV gH showed strongest amino acid identity with human (H) CMV and human herpesvirus 6 gH, and less identity with the gH protein sequences of Epstein-Barr virus, varicella-zoster virus and herpes simplex virus type 1. The greatest identity between MCMV and HCMV gH occurs in the C-terminal region. The MCMV gH is characterized by having a 14 amino acid signal sequence, a 23 amino acid transmembrane region, a seven amino acid positively charged cytoplasmic anchor sequence and eight putative N-linked glycosylation sites. Comparison of MCMV gH with that of HCMV indicates that there are 12 conserved cysteine residues and three conserved potential N-linked glycosylation sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321219     DOI: 10.1099/0022-1317-73-7-1849

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene.

Authors:  R C Brady; M R Schleiss
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.

Authors:  J Vieira; H E Farrell; W D Rawlinson; E S Mocarski
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

3.  Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells.

Authors:  L A Lagenaur; W C Manning; J Vieira; C L Martens; E S Mocarski
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Inactivation of enveloped virus by laser-driven protein aggregation.

Authors:  Shaw-Wei D Tsen; Travis Chapa; Wandy Beatty; Kong-Thon Tsen; Dong Yu; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

5.  Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.

Authors:  Y Duan; S S Atherton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Sayoko Yonemoto; Masato Koike; Masaya Takemoto; Tomohiko Sadaoka; Yumi Sasamoto; Shozo Konishi; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Identification and nucleotide sequence of a gene in feline herpesvirus type 1 homologous to the herpes simplex virus gene encoding the glycoprotein H.

Authors:  K Maeda; Y Kawaguchi; N Kamiya; M Ono; Y Tohya; C Kai; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Identification of proteins associated with murine cytomegalovirus virions.

Authors:  Lisa M Kattenhorn; Ryan Mills; Markus Wagner; Alexandre Lomsadze; Vsevolod Makeev; Mark Borodovsky; Hidde L Ploegh; Benedikt M Kessler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Xuwei Yang; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo.

Authors:  A J Chapman; H E Farrell; J A Thomas; J M Papadimitriou; M J Garlepp; A A Scalzo; G R Shellam
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.